K
KCa2.2 channels
Purkinje cells
cerebellar ataxia
medium afterhyperpolarization
spinocerebellar ataxias
Journal
Journal of neuroscience research
ISSN: 1097-4547
Titre abrégé: J Neurosci Res
Pays: United States
ID NLM: 7600111
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
revised:
05
07
2023
received:
05
03
2023
accepted:
08
07
2023
medline:
11
9
2023
pubmed:
19
7
2023
entrez:
19
7
2023
Statut:
ppublish
Résumé
One group of the K
Substances chimiques
Potassium Channels
0
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1699-1710Subventions
Organisme : NINDS NIH HHS
ID : R33 NS101182
Pays : United States
Informations de copyright
© 2023 The Authors. Journal of Neuroscience Research published by Wiley Periodicals LLC.
Références
Adelman, J. P. (2015). SK channels and calmodulin. Channels, 10, 1-6. https://doi.org/10.1080/19336950.2015.1029688
Aldrich, R., Chandy, K. G., Grissmer, S., Gutman, G. A., Kaczmarek, L. K., Wei, A. D., & Wulff, H. (2021). Calcium- and sodium-activated potassium channels (KCa, KNa) in GtoPdb v.2021.3. IUPHARBPS Guide to Pharmacology CITE, 2021. https://doi.org/10.2218/gtopdb/F69/2021.3
Allen, D., Bond, C. T., Luján, R., Ballesteros-Merino, C., Lin, M. T., Wang, K., Klett, N., Watanabe, M., Shigemoto, R., Stackman Jr, R. W., Maylie, J., & Adelman, J. P. (2011). The SK2-long isoform directs synaptic localization and function of SK2-containing channels. Nature Neuroscience, 14, 744-749. https://doi.org/10.1038/nn.2832
Angstadt, J. D., Rebel, M. I., & Connolly, M. K. (2021). Effects of calcium-activated potassium channel modulators on afterhyperpolarizing potentials in identified motor and mechanosensory neurons of the medicinal leech. Journal of Comparative Physiology. A, Neuroethology, Sensory, Neural, and Behavioral Physiology, 207, 69-85. https://doi.org/10.1007/s00359-021-01462-w
Augustine, G. J., Santamaria, F., & Tanaka, K. (2003). Local calcium signaling in neurons. Neuron, 40, 331-346. https://doi.org/10.1016/S0896-6273(03)00639-1
Balint, B., Guerreiro, R., Carmona, S., Dehghani, N., Latorre, A., Cordivari, C., Bhatia, K. P., & Bras, J. (2020). KCNN2 mutation in autosomal-dominant tremulous myoclonus-dystonia. European Journal of Neurology, 27, 1471-1477. https://doi.org/10.1111/ene.14228
Bardou, O., Trinh, N. T. N., & Brochiero, E. (2009). Canaux potassiques et physiologie de l'épithélium respiratoire. Médecine/Sciences, 25, 391-397. https://doi.org/10.1051/medsci/2009254391
Bond, C. T., Herson, P. S., Strassmaier, T., Hammond, R., Stackman, R., Maylie, J., & Adelman, J. P. (2004). Small conductance Ca2+-activated K+ channel knock-out mice reveal the identity of calcium-dependent afterhyperpolarization currents. The Journal of Neuroscience, 24, 5301-5306. https://doi.org/10.1523/JNEUROSCI.0182-04.2004
Braga, M. F. M., & Rowan, E. G. (1994). The pharmacological effects of cadmium on skeletal neuromuscular transmission. General Pharmacology, 25, 1729-1739. https://doi.org/10.1016/0306-3623(94)90379-4
Brooker, S. M., Edamakanti, C. R., Akasha, S. M., Kuo, S.-H., & Opal, P. (2021). Spinocerebellar ataxia clinical trials: Opportunities and challenges. Annals of Clinical Translational Neurology, 8, 1543-1556. https://doi.org/10.1002/acn3.51370
Brown, B. M., Shim, H., Christophersen, P., & Wulff, H. (2020). Pharmacology of small- and intermediate-conductance calcium-activated potassium channels. Annual Review of Pharmacology and Toxicology, 60, 219-240. https://doi.org/10.1146/annurev-pharmtox-010919-023420
Bushart, D. D., Chopra, R., Singh, V., Murphy, G. G., Wulff, H., & Shakkottai, V. G. (2018). Targeting potassium channels to treat cerebellar ataxia. Annals of Clinical Translational Neurology, 5, 297-314. https://doi.org/10.1002/acn3.527
Cao, Y., Dreixler, J. C., Roizen, J. D., Roberts, M. T., & Houamed, K. M. (2001). Modulation of recombinant small-conductance Ca(2+)-activated K(+) channels by the muscle relaxant chlorzoxazone and structurally related compounds. The Journal of Pharmacology and Experimental Therapeutics, 296, 683-689.
Chen, M. X., Gorman, S. A., Benson, B., Singh, K., Hieble, J. P., Michel, M. C., Tate, S. N., & Trezise, D. J. (2004). Small and intermediate conductance Ca2+−activated K+ channels confer distinctive patterns of distribution in human tissues and differential cellular localisation in the colon and corpus cavernosum. Naunyn-Schmiedeberg's Archives of Pharmacology, 369, 602-615. https://doi.org/10.1007/s00210-004-0934-5
Chen, T., Zhu, J., Hang, C.-H., & Wang, Y.-H. (2019). The potassium SK channel activator NS309 protects against experimental traumatic brain injury through anti-inflammatory and immunomodulatory mechanisms. Frontiers in Pharmacology, 10, 10.
Dimitriadi, M., Kye, M. J., Kalloo, G., Yersak, J. M., Sahin, M., & Hart, A. C. (2013). The neuroprotective drug Riluzole acts via small conductance Ca2+-activated K+ channels to ameliorate defects in spinal muscular atrophy models. The Journal of Neuroscience, 33, 6557-6562. https://doi.org/10.1523/JNEUROSCI.1536-12.2013
Diness, J. G., Sørensen, U. S., Nissen, J. D., Al-Shahib, B., Jespersen, T., Grunnet, M., & Hansen, R. S. (2010). Inhibition of small-conductance Ca2+-activated K+ channels terminates and protects against atrial fibrillation. Circulation. Arrhythmia and Electrophysiology, 3, 380-390. https://doi.org/10.1161/CIRCEP.110.957407
Dwivedi, D., & Bhalla, U. S. (2021). Physiology and therapeutic potential of SK, H, and M medium afterhyperpolarization ion channels. Frontiers in Molecular Neuroscience, 14, 658435. https://doi.org/10.3389/fnmol.2021.658435
Fakler, B., & Adelman, J. P. (2008). Control of KCa channels by calcium nano/microdomains. Neuron, 59, 873-881. https://doi.org/10.1016/j.neuron.2008.09.001
Girault, A., Haelters, J.-P., Potier-Cartereau, M., Chantôme, A., Jaffrés, P.-A., Bougnoux, P., Joulin, V., & Vandier, C. (2012). Targeting SKCa channels in cancer: Potential new therapeutic approaches. Current Medicinal Chemistry, 19, 697-713. https://doi.org/10.2174/092986712798992039
González, C., Baez-Nieto, D., Valencia, I., Oyarzún, I., Rojas, P., Naranjo, D., & Latorre, R. (2012). K(+) channels: Function-structural overview. Comprehensive Physiology, 2, 2087-2149. https://doi.org/10.1002/cphy.c110047
Hammond, R. S., Bond, C. T., Strassmaier, T., Ngo-Anh, T. J., Adelman, J. P., Maylie, J., & Stackman, R. W. (2006). Small-conductance Ca2+−activated K+ channel type 2 (SK2) modulates hippocampal learning, memory, and synaptic plasticity. Journal of Neuroscience, 26, 1844-1853. https://doi.org/10.1523/JNEUROSCI.4106-05.2006
Hosy, E., Piochon, C., Teuling, E., Rinaldo, L., & Hansel, C. (2011). SK2 channel expression and function in cerebellar Purkinje cells. The Journal of Physiology, 589, 3433-3440. https://doi.org/10.1113/jphysiol.2011.205823
Hougaard, C., Jensen, M. L., Dale, T. J., Miller, D. D., Davies, D. J., Eriksen, B. L., Strøbaek, D., Trezise, D. J., & Christophersen, P. (2009). Selective activation of the SK1 subtype of human small-conductance Ca2+−activated K+ channels by 4-(2-methoxyphenylcarbamoyloxymethyl)-piperidine-1-carboxylic acid tert-butyl ester (GW542573X) is dependent on serine 293 in the S5 segment. Molecular Pharmacology, 76, 569-578. https://doi.org/10.1124/mol.109.056663
Humphries, E. S. A., & Dart, C. (2015). Neuronal and cardiovascular potassium channels as therapeutic drug targets. Journal of Biomolecular Screening, 20, 1055-1073. https://doi.org/10.1177/1087057115601677
Ishii, T. M., Maylie, J., & Adelman, J. P. (1997). Determinants of apamin and d-tubocurarine block in SK potassium channels. The Journal of Biological Chemistry, 272, 23195-23200. https://doi.org/10.1074/jbc.272.37.23195
Jäger, H., Adelman, J. P., & Grissmer, S. (2000). SK2 encodes the apamin-sensitive Ca2+−activated K+ channels in the human leukemic T cell line, Jurkat. FEBS Letters, 469(2-3), 196-202. https://www.researchgate.net/publication/12603068_SK2_encodes_the_apamin-sensitive_Ca2-activated_K_channels_in_the_human_leukemic_T_cell_line_Jurkat
Jenkins, D. P., Strøbaek, D., Hougaard, C., Jensen, M. L., Hummel, R., Sørensen, U. S., Christophersen, P., & Wulff, H. (2011). Negative gating modulation by (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine (NS8593) depends on residues in the inner pore vestibule: Pharmacological evidence of deep-pore gating of KCa2 channels. Molecular Pharmacology, 79, 899-909. https://doi.org/10.1124/mol.110.069807
Jiang, Y., Lee, A., Chen, J., Cadene, M., Chait, B. T., & MacKinnon, R. (2002). The open pore conformation of potassium channels. Nature, 417, 523-526. https://doi.org/10.1038/417523a
John, C. M., Khaddaj Mallat, R., Mishra, R. C., George, G., Singh, V., Turnbull, J. D., Umeshappa, C. S., Kendrick, D. J., Kim, T., Fauzi, F. M., Visser, F., Fedak, P. W. M., Wulff, H., & Braun, A. P. (2020). SKA-31, an activator of Ca2+−activated K+ channels, improves cardiovascular function in aging. Pharmacological Research, 151, 104539. https://doi.org/10.1016/j.phrs.2019.104539
Klockgether, T., Mariotti, C., & Paulson, H. L. (2019). Spinocerebellar ataxia. Nature Reviews Disease Primers, 5, 24. https://doi.org/10.1038/s41572-019-0074-3
Köhler, M., Hirschberg, B., Bond, C. T., Kinzie, J. M., Marrion, N. V., Maylie, J., & Adelman, J. P. (1996). Small-conductance, calcium-activated potassium channels from mammalian brain. Science, 273, 1709-1714. https://doi.org/10.1126/science.273.5282.1709
Krysa, W., Sulek, A., Rakowicz, M., Szirkowiec, W., & Zaremba, J. (2016). High relative frequency of SCA1 in Poland reflecting a potential founder effect. Neurological Sciences, 37, 1319-1325. https://doi.org/10.1007/s10072-016-2594-x
Kuang, Q., Purhonen, P., & Hebert, H. (2015). Structure of potassium channels. Cellular and Molecular Life Sciences, 72, 3677-3693. https://doi.org/10.1007/s00018-015-1948-5
Kuramoto, T., Yokoe, M., Kunisawa, N., Ohashi, K., Miyake, T., Higuchi, Y., Yoshimi, K., Mashimo, T., Tanaka, M., Kuwamura, M., Kaneko, S., Shimizu, S., Serikawa, T., & Ohno, Y. (2017). Tremor dominant Kyoto (Trdk) rats carry a missense mutation in the gene encoding the SK2 subunit of small-conductance Ca2+−activated K+ channel. Brain Research, 1676, 38-45. https://doi.org/10.1016/j.brainres.2017.09.012
Lam, J., Coleman, N., Garing, A. L. A., & Wulff, H. (2013). The therapeutic potential of small-conductance KCa2 channels in neurodegenerative and psychiatric diseases. Expert Opinion on Therapeutic Targets, 17, 1203-1220. https://doi.org/10.1517/14728222.2013.823161
Lamy, C., Goodchild, S. J., Weatherall, K. L., Jane, D. E., Liégeois, J.-F., Seutin, V., & Marrion, N. V. (2010). Allosteric block of KCa2 channels by apamin. The Journal of Biological Chemistry, 285, 27067-27077. https://doi.org/10.1074/jbc.M110.110072
Lin, M. T., Luján, R., Watanabe, M., Adelman, J. P., & Maylie, J. (2008). SK2 channel plasticity contributes to LTP at Schaffer collateral-CA1 synapses. Nature Neuroscience, 11, 170-177. https://doi.org/10.1038/nn2041
Littleton, J. T., & Ganetzky, B. (2000). Ion channels and synaptic organization: Analysis of the drosophila genome. Neuron, 26, 35-43. https://doi.org/10.1016/s0896-6273(00)81135-6
Liu, Y., Sato, T., O'Rourke, B., & Marban, E. (1998). Mitochondrial ATP-dependent potassium channels. Circulation, 97, 2463-2469. https://doi.org/10.1161/01.CIR.97.24.2463
Miller, C. (2000). An overview of the potassium channel family. Genome Biology, 1, REVIEWS0004. https://doi.org/10.1186/gb-2000-1-4-reviews0004
Mochel, F., Rastetter, A., Ceulemans, B., Platzer, K., Yang, S., Shinde, D. N., Helbig, K. L., Lopergolo, D., Mari, F., Renieri, A., Benetti, E., Canitano, R., Waisfisz, Q., Plomp, A. S., Huisman, S. A., Wilson, G. N., Cathey, S. S., Louie, R. J., del Gaudio, D., … Depienne, C. (2020). Variants in the SK2 channel gene (KCNN2) lead to dominant neurodevelopmental movement disorders. Brain: A Journal of Neurology, 143, 3564-3573. https://doi.org/10.1093/brain/awaa346
Mourre, C., Manrique, C., Camon, J., Aidi-Knani, S., Deltheil, T., Turle-Lorenzo, N., Guiraudie-Capraz, G., & Amalric, M. (2017). Changes in SK channel expression in the basal ganglia after partial nigrostriatal dopamine lesions in rats: Functional consequences. Neuropharmacology, 113, 519-532. https://doi.org/10.1016/j.neuropharm.2016.11.003
Müller, U. (2021). Spinocerebellar ataxias (SCAs) caused by common mutations. Neurogenetics, 22, 235-250. https://doi.org/10.1007/s10048-021-00662-5
Murthy, S. R. K., Sherrin, T., Jansen, C., Nijholt, I., Robles, M., Dolga, A. M., Andreotti, N., Sabatier, J. M., Knaus, H. G., Penner, R., Todorovic, C., & Blank, T. (2015). Small-conductance Ca2+−activated potassium type 2 channels regulate the formation of contextual fear memory. PLoS One, 10, e0127264. https://doi.org/10.1371/journal.pone.0127264
Nam, Y.-W., Cui, M., el-Sayed, N. S., Orfali, R., Nguyen, M., Yang, G., Rahman, M. A., Lee, J., & Zhang, M. (2022). Subtype-selective positive modulation of KCa2 channels depends on the HA/HB helices. British Journal of Pharmacology, 179, 460-472. https://doi.org/10.1111/bph.15676
Nam, Y.-W., Downey, M., Rahman, M. A., Cui, M., & Zhang, M. (2023). Channelopathy of small- and intermediate-conductance Ca2+−activated K+ channels. Acta Pharmacologica Sinica, 44, 259-267. https://doi.org/10.1038/s41401-022-00935-1
Nam, Y.-W., Kong, D., Wang, D., Orfali, R., Sherpa, R. T., Totonchy, J., Nauli, S. M., & Zhang, M. (2021). Differential modulation of SK channel subtypes by phosphorylation. Cell Calcium, 94, 102346. https://doi.org/10.1016/j.ceca.2020.102346
Nam, Y.-W., Orfali, R., Liu, T., Yu, K., Cui, M., Wulff, H., & Zhang, M. (2017). Structural insights into the potency of SK channel positive modulators. Scientific Reports, 7, 17178. https://doi.org/10.1038/s41598-017-16607-8
Nam, Y.-W., Rahman, M. A., Yang, G., Orfali, R., Cui, M., & Zhang, M. (2023). Loss-of-function KCa2.2 mutations abolish channel activity. American Journal of Physiology-Cell Physiology, 324, C658-C664. https://doi.org/10.1152/ajpcell.00584.2022
Naseem, M. U., Gurrola-Briones, G., Romero-Imbachi, M. R., Borrego, J., Carcamo-Noriega, E., Beltrán-Vidal, J., Zamudio, F. Z., Shakeel, K., Possani, L. D., & Panyi, G. (2023). Characterization and chemical synthesis of Cm39 (α-KTx 4.8): A scorpion toxin that inhibits voltage-gated K+ channel KV1.2 and small- and intermediate-conductance Ca2+-activated K+ channels KCa2.2 and KCa3.1. Toxins, 15, 41. https://doi.org/10.3390/toxins15010041
Ngo-Anh, T. J., Bloodgood, B. L., Lin, M., Sabatini, B. L., Maylie, J., & Adelman, J. P. (2005). SK channels and NMDA receptors form a Ca2+−mediated feedback loop in dendritic spines. Nature Neuroscience, 8, 642-649. https://doi.org/10.1038/nn1449
Oliván-Viguera, A., Valero, M. S., Coleman, N., Brown, B. M., Laría, C., Murillo, M. D., Gálvez, J. A., Díaz-de-Villegas, M. D., Wulff, H., Badorrey, R., & Köhler, R. (2015). A novel pan-negative-gating modulator of KCa2/3 channels, fluoro-di-benzoate, RA-2, inhibits endothelium-derived hyperpolarization-type relaxation in coronary artery and produces bradycardia in vivo. Molecular Pharmacology, 87, 338-348. https://doi.org/10.1124/mol.114.095745
Orfali, R., & Albanyan, N. (2023). Ca2+-sensitive potassium channels. Molecules, 28, 885. https://doi.org/10.3390/molecules28020885
Orfali, R., Nam, Y.-W., Nguyen, H. M., Rahman, M. A., Yang, G., Cui, M., Wulff, H., & Zhang, M. (2022). Channelopathy-causing mutations in the S45A/S45B and HA/HB helices of KCa2.3 and KCa3.1 channels alter their apparent Ca2+ sensitivity. Cell Calcium, 102, 102538. https://doi.org/10.1016/j.ceca.2022.102538
Park, H. Y., Kim, S. A., Korlach, J., Rhoades, E., Kwok, L. W., Zipfel, W. R., Waxham, M. N., Webb, W. W., & Pollack, L. (2008). Conformational changes of calmodulin upon Ca2+ binding studied with a microfluidic mixer. Proceedings of the National Academy of Sciences, 105, 542-547. https://doi.org/10.1073/pnas.0710810105
Pedarzani, P., McCutcheon, J. E., Rogge, G., Jensen, B. S., Christophersen, P., Hougaard, C., Strøbaek, D., & Stocker, M. (2005). Specific enhancement of SK channel activity selectively potentiates the afterhyperpolarizing current I(AHP) and modulates the firing properties of hippocampal pyramidal neurons. The Journal of Biological Chemistry, 280, 41404-41411. https://doi.org/10.1074/jbc.M509610200
Pedarzani, P., Mosbacher, J., Rivard, A., Cingolani, L. A., Oliver, D., Stocker, M., Adelman, J. P., & Fakler, B. (2001). Control of electrical activity in central neurons by modulating the gating of small conductance Ca2+−activated K+ channels. The Journal of Biological Chemistry, 276, 9762-9769. https://doi.org/10.1074/jbc.M010001200
Pedarzani, P., & Stocker, M. (2008). Molecular and cellular basis of small- and intermediate-conductance, calcium-activated potassium channel function in the brain. Cellular and Molecular Life Sciences, 65, 3196-3217. https://doi.org/10.1007/s00018-008-8216-x
Qi, M.-M., Qian, L.-L., & Wang, R.-X. (2021). Modulation of SK channels: Insight into therapeutics of atrial fibrillation. Heart, Lung & Circulation, 30, 1130-1139. https://doi.org/10.1016/j.hlc.2021.01.009
Rahm, A., Wieder, T., Gramlich, D., Müller, M. E., Wunsch, M. N., el Tahry, F. A., Heimberger, T., Sandke, S., Weis, T., Most, P., Katus, H. A., Thomas, D., & Lugenbiel, P. (2021). Differential regulation of KCa2.1 (KCNN1) K+ channel expression by histone deacetylases in atrial fibrillation with concomitant heart failure. Physiological Reports, 9, e14835. https://doi.org/10.14814/phy2.14835
Ruano, L., Melo, C., Silva, M. C., & Coutinho, P. (2014). The global epidemiology of hereditary ataxia and spastic paraplegia: A systematic review of prevalence studies. Neuroepidemiology, 42, 174-183. https://doi.org/10.1159/000358801
Sailer, C. A., Kaufmann, W. A., Marksteiner, J., & Knaus, H.-G. (2004). Comparative immunohistochemical distribution of three small-conductance Ca2+−activated potassium channel subunits, SK1, SK2, and SK3 in mouse brain. Molecular and Cellular Neurosciences, 26, 458-469. https://doi.org/10.1016/j.mcn.2004.03.002
Sansom, M. S. P., Shrivastava, I. H., Bright, J. N., Tate, J., Capener, C. E., & Biggin, P. C. (2002). Potassium channels: structures, models, simulations. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1565, 294-307. https://doi.org/10.1016/S0005-2736(02)00576-X
Shakkottai, V. G., do Carmo Costa, M., Dell'Orco, J. M., Sankaranarayanan, A., Wulff, H., & Paulson, H. L. (2011). Early changes in cerebellar physiology accompany motor dysfunction in the polyglutamine disease spinocerebellar ataxia type 3. Rapid communications, 31, 13002-13014. https://doi.org/10.1523/JNEUROSCI.2789-11.2011
Shieh, C. C., Coghlan, M., Sullivan, J. P., & Gopalakrishnan, M. (2000). Potassium channels: Molecular defects, diseases, and therapeutic opportunities. Pharmacological Reviews, 52, 557-594.
Skibsbye, L., Poulet, C., Diness, J. G., Bentzen, B. H., Yuan, L., Kappert, U., Matschke, K., Wettwer, E., Ravens, U., Grunnet, M., Christ, T., & Jespersen, T. (2014). Small-conductance calcium-activated potassium (SK) channels contribute to action potential repolarization in human atria. Cardiovascular Research, 103, 156-167. https://doi.org/10.1093/cvr/cvu121
Soong, B.-W., & Morrison, P. J. (2018). Spinocerebellar ataxias. Handbook of Clinical Neurology, 155, 143-174. https://doi.org/10.1016/B978-0-444-64189-2.00010-X
Stocker, M. (2004). Ca(2+)-activated K+ channels: Molecular determinants and function of the SK family. Nature Reviews. Neuroscience, 5, 758-770. https://doi.org/10.1038/nrn1516
Stocker, M., Krause, M., & Pedarzani, P. (1999). An apamin-sensitive Ca2+−activated K+ current in hippocampal pyramidal neurons. Proceedings of the National Academy of Sciences, 96, 4662-4667. https://doi.org/10.1073/pnas.96.8.4662
Strassmaier, T., Bond, C. T., Sailer, C. A., Knaus, H.-G., Maylie, J., & Adelman, J. P. (2005). A novel isoform of SK2 assembles with other SK subunits in mouse brain. The Journal of Biological Chemistry, 280, 21231-21236. https://doi.org/10.1074/jbc.M413125200
Teive, H. A. G. (2009). Spinocerebellar ataxias. Arquivos de Neuro-Psiquiatria, 67, 1133-1142.
Teive, H. A. G., Meira, A. T., Camargo, C. H. F., & Munhoz, R. P. (2019). The geographic diversity of spinocerebellar ataxias (SCAs) in the Americas: A systematic review. Movement Disorders Clinical Practice, 6, 531-540. https://doi.org/10.1002/mdc3.12822
Tsantoulas, C., & McMahon, S. B. (2014). Opening paths to novel analgesics: The role of potassium channels in chronic pain. Trends in Neurosciences, 37, 146-158. https://doi.org/10.1016/j.tins.2013.12.002
Vishwakarma, P., Muthuswamy, S., & Agarwal, S. (2018). Current molecular insight to reveal the dynamics of CAG repeating units in spinocerebellar ataxia. Intractable & Rare Diseases Research, 7, 79-86. https://doi.org/10.5582/irdr.2018.01039
Weatherall, K. L., Goodchild, S. J., Jane, D. E., & Marrion, N. V. (2010). Small conductance calcium-activated potassium channels: From structure to function. Progress in Neurobiology, 91, 242-255. https://doi.org/10.1016/j.pneurobio.2010.03.002
Weaver, A. K., Bomben, V. C., & Sontheimer, H. (2006). Expression and function of calcium-activated potassium channels in human glioma cells. Glia, 54, 223-233. https://doi.org/10.1002/glia.20364
Weisbrod, D., Khun, S. H., Bueno, H., Peretz, A., & Attali, B. (2016). Mechanisms underlying the cardiac pacemaker: The role of SK4 calcium-activated potassium channels. Acta Pharmacologica Sinica, 37, 82-97. https://doi.org/10.1038/aps.2015.135
Willis, M., Trieb, M., Leitner, I., Wietzorrek, G., Marksteiner, J., & Knaus, H.-G. (2017). Small-conductance calcium-activated potassium type 2 channels (SK2, KCa2.2) in human brain. Brain Structure & Function, 222, 973-979. https://doi.org/10.1007/s00429-016-1258-1
Womack, M. D., & Khodakhah, K. (2003). Somatic and dendritic small-conductance calcium-activated potassium channels regulate the output of cerebellar Purkinje neurons. The Journal of Neuroscience, 23, 2600-2607. https://doi.org/10.1523/JNEUROSCI.23-07-02600.2003
Wulff, H., & Köhler, R. (2013). Endothelial small- and intermediate-conductance KCa channels: An update on their pharmacology and usefulness as cardiovascular targets. Journal of Cardiovascular Pharmacology, 61, 102-112. https://doi.org/10.1097/FJC.0b013e318279ba20
Xia, X.-M., Fakler, B., Rivard, A., Wayman, G., Johnson-Pais, T., Keen, J. E., Ishii, T., Hirschberg, B., Bond, C. T., Lutsenko, S., Maylie, J., & Adelman, J. P. (1998). Mechanism of calcium gating in small-conductance calcium-activated potassium channels. Nature, 395, 503-507. https://doi.org/10.1038/26758
Xu, Y., Tuteja, D., Zhang, Z., Xu, D., Zhang, Y., Rodriguez, J., Nie, L., Tuxson, H. R., Young, J. N., Glatter, K. A., Vázquez, A. E., Yamoah, E. N., & Chiamvimonvat, N. (2003). Molecular identification and functional roles of a Ca(2+)-activated K+ channel in human and mouse hearts. The Journal of Biological Chemistry, 278, 49085-49094. https://doi.org/10.1074/jbc.M307508200
Zhang, M., Meng, X.-Y., Cui, M., Pascal, J. M., Logothetis, D. E., & Zhang, J.-F. (2014). Selective phosphorylation modulates the PIP2 sensitivity of the CaM-SK channel complex. Nature Chemical Biology, 10, 753-759. https://doi.org/10.1038/nchembio.1592
Zhang, X.-D., Thai, P. N., Lieu, D. K., & Chiamvimonvat, N. (2021). Cardiac small-conductance calcium-activated potassium channels in health and disease. Pflügers Archiv, 473, 477-489. https://doi.org/10.1007/s00424-021-02535-0
Zheng, J., & Trudeau, M. C. (2023). Textbook of ion channels volume II: Properties, function, and pharmacology of the superfamilies. CRC Press.